Spray-dried lactose-leucine microparticles for pulmonary delivery of antimycobacterial nanopharmaceuticals.

Autor: Thiyagarajan D; Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research (HZI), Campus E8.1, 66123, Saarbrucken, Germany., Huck B; Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research (HZI), Campus E8.1, 66123, Saarbrucken, Germany.; Department of Pharmacy, Saarland University, 66123, Saarbrucken, Germany., Nothdurft B; INM - Leibniz Institute for New Materials, Campus D2 2, 66123, Saarbrucken, Germany., Koch M; INM - Leibniz Institute for New Materials, Campus D2 2, 66123, Saarbrucken, Germany., Rudolph D; Institute of Inorganic Chemistry, Karlsruhe Institute of Technology (KIT), Engesserstr. 15, 76131, Karlsruhe, Germany., Rutschmann M; Institute of Inorganic Chemistry, Karlsruhe Institute of Technology (KIT), Engesserstr. 15, 76131, Karlsruhe, Germany., Feldmann C; Institute of Inorganic Chemistry, Karlsruhe Institute of Technology (KIT), Engesserstr. 15, 76131, Karlsruhe, Germany., Hozsa C; Rodos Biotarget GmbH, Feodor-Lynen-Str. 31, 30625, Hannover, Germany.; Siegfried AG Hameln, 31789, Hameln, Germany., Furch M; Rodos Biotarget GmbH, Feodor-Lynen-Str. 31, 30625, Hannover, Germany.; Biolife Holding GmbH & Co. KG, 69126, Heidelberg, Germany., Besecke KFW; Rodos Biotarget GmbH, Feodor-Lynen-Str. 31, 30625, Hannover, Germany., Gieseler RK; Rodos Biotarget GmbH, Feodor-Lynen-Str. 31, 30625, Hannover, Germany.; Department of Medicine, University Hospital Bochum, 44892, Bochum, Germany., Loretz B; Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research (HZI), Campus E8.1, 66123, Saarbrucken, Germany. Brigitta.Loretz@helmholtz-hips.de., Lehr CM; Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research (HZI), Campus E8.1, 66123, Saarbrucken, Germany.; Department of Pharmacy, Saarland University, 66123, Saarbrucken, Germany.

Publikováno v: Drug delivery and translational research [Drug Deliv Transl Res] 2021 Aug; Vol. 11 (4), pp. 1766-1778. Date of Electronic Publication: 2021 Jun 08.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Novel therapeutic approach for the treatment of cystic fibrosis based on freeze-dried tridrug microparticles to treat cystic fibrosis.

Autor: Kabra, Vinayak D.¹ (AUTHOR), Lahoti, Swaroop R.¹ (AUTHOR) pharmalahoti@gmail.com

Publikováno v: DARU: Journal of Pharmaceutical Sciences. Jun2023, Vol. 31 Issue 1, p39-50. 12p.

Impact of dispersion media and carrier type on spray-dried proliposome powder formulations loaded with beclomethasone dipropionate for their pulmonary drug delivery via a next generation impactor.

Autor: Khan, Iftikhar¹ (AUTHOR) I.Khan@ljmu.ac.uk, Al-Hasani, Ali¹ (AUTHOR), Khan, Mohsin H.² (AUTHOR), Khan, Aamir N.³ (AUTHOR), -Alam, Fakhr-e⁴ (AUTHOR), Sadozai, Sajid K.⁵ (AUTHOR), Elhissi, Abdelbary⁶ (AUTHOR), Khan, Jehanzeb⁷ (AUTHOR), Yousaf, Sakib¹ (AUTHOR)

Publikováno v: PLoS ONE. 3/13/2023, Vol. 17 Issue 3, p1-19. 19p.

Development and Pharmacokinetics of a Novel Acetylsalicylic Acid Dry Powder for Pulmonary Administration.

Autor: Pacławski, Adam¹ (AUTHOR), Politis, Stavros² (AUTHOR), Balafas, Evangelos³ (AUTHOR), Mina, Ekaterini² (AUTHOR), Papakyriakopoulou, Paraskevi² (AUTHOR), Christodoulou, Eirini² (AUTHOR), Kostomitsopoulos, Nikolaos³ (AUTHOR), Rekkas, Dimitrios M.² (AUTHOR) rekkas@pharm.uoa.gr, Valsami, Georgia² (AUTHOR), Giovagnoli, Stefano⁴ (AUTHOR) rekkas@pharm.uoa.gr

Publikováno v: Pharmaceutics. Dec2022, Vol. 14 Issue 12, p2819. 17p.